{"id":450751,"date":"2021-03-04T08:48:04","date_gmt":"2021-03-04T13:48:04","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=450751"},"modified":"2021-03-04T08:48:04","modified_gmt":"2021-03-04T13:48:04","slug":"jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\/","title":{"rendered":"Jabil Healthcare Signs Strategic Collaboration Agreement with E3D, Expanding Pharmaceutical Market Offering"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Jabil Healthcare Signs Strategic Collaboration Agreement with E3D, Expanding Pharmaceutical Market Offering<\/b><\/p>\n<p class=\"bwalignc\"><i>Agreement provides Jabil with exclusive license to develop drug delivery device product platform based on E3D mechanical multi-use auto-injector technology<\/i><\/p>\n<p>ST. PETERSBURG, Fla.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.jabil.com%2Findustries%2Fhealthcare.html&amp;esheet=52390256&amp;newsitemid=20210304005104&amp;lan=en-US&amp;anchor=Jabil+Healthcare&amp;index=1&amp;md5=8aa63bcd2ebfb1d9c9344d6aca4a920b\">Jabil Healthcare<\/a>, a division of Jabil Inc. (NYSE: JBL), today announced it has entered a strategic collaboration agreement with global drug delivery device company <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.elcam3d.com%2F&amp;esheet=52390256&amp;newsitemid=20210304005104&amp;lan=en-US&amp;anchor=E3D&amp;index=2&amp;md5=c989eb7cdd3122ffd9e1a384f103b82d\">E3D<\/a>, a member of the Elcam Medical Group, which gives Jabil access to E3D\u2019s reusable mechanical auto-injector. Under the terms of this deal, Jabil has secured exclusive rights to develop a high-volume reusable auto-injector and connected variants.\n<\/p>\n<p>\nThe agreement enables Jabil Healthcare to further develop connected auto-injectors for a range of dosing volumes and patient-centric benefits, ultimately creating a platform of devices. Jabil Healthcare applies its expertise to help customers through the design, development and manufacture of some of the most complex and innovative drug delivery devices in the market.\n<\/p>\n<p>\n\u201cOur collaboration with E3D enhances Jabil\u2019s development of pharmaceutical solutions that move us into the future of connected, digital devices that are more intuitive, economical and sustainable,\u201d said James O\u2019Gorman, vice president, Pharmaceutical Delivery Systems (PDS), Jabil Healthcare. \u201cThis is an exciting expansion of our relationship with E3D that will benefit our market offering and healthcare customers alike.\u201d\n<\/p>\n<p>\n\u201cAs a leader in the healthcare arena, Jabil Healthcare is the perfect partner for us and for a drug delivery market that requires the highest levels of competence, experience and scale in manufacturing,\u201d said Tsachi Shaked, general manager of E3D. \u201cOur complementary expertise in electronics, manufacturing and data analysis is the type of collaboration that should help speed advances and adoption of digital health technologies.\u201d\n<\/p>\n<p>\nJabil Healthcare\u2019s Pharmaceutical Delivery Systems business is relied on by many of the world\u2019s leading healthcare brands to execute large New Product Introductions (NPI) and ramp into commercial production, applying proven manufacturing processes to reduce risk and overall cost. Together, Jabil Healthcare and E3D form a comprehensive offering of pre-launch support, including full global commercial supply, lifecycle management, final product assembly, labeling and legal manufacturing services.\n<\/p>\n<p><b>About Jabil <\/b><\/p>\n<p>\nJabil (NYSE: JBL) is a manufacturing solutions provider with over 260,000 employees across 100 locations in 30 countries. The world&#8217;s leading brands rely on Jabil&#8217;s unmatched breadth and depth of end-market experience, technical and design capabilities, manufacturing know-how, supply chain insights and global product management expertise. Driven by a common purpose, Jabil and its people are committed to making a positive impact on their local community and the environment. Visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.jabil.com&amp;esheet=52390256&amp;newsitemid=20210304005104&amp;lan=en-US&amp;anchor=www.jabil.com&amp;index=3&amp;md5=5186b0629f1bbf9b65eab7d3fce537e3\">www.jabil.com<\/a> to learn more.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210304005104r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210304005104\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210304005104\/en\/<\/a><\/span><\/p>\n<p>\nMichelle Smith, VP Communications &amp; Brand Strategy, Jabil<br \/>\n<br \/>(813) 415.1116<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:michelle_smith@jabil.com\">michelle_smith@jabil.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America Florida<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Other Manufacturing Manufacturing<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210304005104\/en\/824242\/3\/JabilMasterBrand_PMS2955_PMS298.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Jabil Healthcare Signs Strategic Collaboration Agreement with E3D, Expanding Pharmaceutical Market Offering Agreement provides Jabil with exclusive license to develop drug delivery device product platform based on E3D mechanical multi-use auto-injector technology ST. PETERSBURG, Fla.&#8211;(BUSINESS WIRE)&#8211;Jabil Healthcare, a division of Jabil Inc. (NYSE: JBL), today announced it has entered a strategic collaboration agreement with global drug delivery device company E3D, a member of the Elcam Medical Group, which gives Jabil access to E3D\u2019s reusable mechanical auto-injector. Under the terms of this deal, Jabil has secured exclusive rights to develop a high-volume reusable auto-injector and connected variants. The agreement enables Jabil Healthcare to further develop connected auto-injectors for a range of dosing volumes and patient-centric benefits, ultimately creating a platform of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Jabil Healthcare Signs Strategic Collaboration Agreement with E3D, Expanding Pharmaceutical Market Offering&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-450751","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Jabil Healthcare Signs Strategic Collaboration Agreement with E3D, Expanding Pharmaceutical Market Offering - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Jabil Healthcare Signs Strategic Collaboration Agreement with E3D, Expanding Pharmaceutical Market Offering - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Jabil Healthcare Signs Strategic Collaboration Agreement with E3D, Expanding Pharmaceutical Market Offering Agreement provides Jabil with exclusive license to develop drug delivery device product platform based on E3D mechanical multi-use auto-injector technology ST. PETERSBURG, Fla.&#8211;(BUSINESS WIRE)&#8211;Jabil Healthcare, a division of Jabil Inc. (NYSE: JBL), today announced it has entered a strategic collaboration agreement with global drug delivery device company E3D, a member of the Elcam Medical Group, which gives Jabil access to E3D\u2019s reusable mechanical auto-injector. Under the terms of this deal, Jabil has secured exclusive rights to develop a high-volume reusable auto-injector and connected variants. The agreement enables Jabil Healthcare to further develop connected auto-injectors for a range of dosing volumes and patient-centric benefits, ultimately creating a platform of &hellip; Continue reading &quot;Jabil Healthcare Signs Strategic Collaboration Agreement with E3D, Expanding Pharmaceutical Market Offering&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-04T13:48:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210304005104r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Jabil Healthcare Signs Strategic Collaboration Agreement with E3D, Expanding Pharmaceutical Market Offering\",\"datePublished\":\"2021-03-04T13:48:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\\\/\"},\"wordCount\":480,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210304005104r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\\\/\",\"name\":\"Jabil Healthcare Signs Strategic Collaboration Agreement with E3D, Expanding Pharmaceutical Market Offering - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210304005104r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-03-04T13:48:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210304005104r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210304005104r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Jabil Healthcare Signs Strategic Collaboration Agreement with E3D, Expanding Pharmaceutical Market Offering\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Jabil Healthcare Signs Strategic Collaboration Agreement with E3D, Expanding Pharmaceutical Market Offering - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\/","og_locale":"en_US","og_type":"article","og_title":"Jabil Healthcare Signs Strategic Collaboration Agreement with E3D, Expanding Pharmaceutical Market Offering - Market Newsdesk","og_description":"Jabil Healthcare Signs Strategic Collaboration Agreement with E3D, Expanding Pharmaceutical Market Offering Agreement provides Jabil with exclusive license to develop drug delivery device product platform based on E3D mechanical multi-use auto-injector technology ST. PETERSBURG, Fla.&#8211;(BUSINESS WIRE)&#8211;Jabil Healthcare, a division of Jabil Inc. (NYSE: JBL), today announced it has entered a strategic collaboration agreement with global drug delivery device company E3D, a member of the Elcam Medical Group, which gives Jabil access to E3D\u2019s reusable mechanical auto-injector. Under the terms of this deal, Jabil has secured exclusive rights to develop a high-volume reusable auto-injector and connected variants. The agreement enables Jabil Healthcare to further develop connected auto-injectors for a range of dosing volumes and patient-centric benefits, ultimately creating a platform of &hellip; Continue reading \"Jabil Healthcare Signs Strategic Collaboration Agreement with E3D, Expanding Pharmaceutical Market Offering\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-04T13:48:04+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210304005104r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Jabil Healthcare Signs Strategic Collaboration Agreement with E3D, Expanding Pharmaceutical Market Offering","datePublished":"2021-03-04T13:48:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\/"},"wordCount":480,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210304005104r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\/","name":"Jabil Healthcare Signs Strategic Collaboration Agreement with E3D, Expanding Pharmaceutical Market Offering - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210304005104r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-03-04T13:48:04+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210304005104r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210304005104r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jabil-healthcare-signs-strategic-collaboration-agreement-with-e3d-expanding-pharmaceutical-market-offering\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Jabil Healthcare Signs Strategic Collaboration Agreement with E3D, Expanding Pharmaceutical Market Offering"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/450751","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=450751"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/450751\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=450751"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=450751"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=450751"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}